Vertex Pharmaceuticals

$211.58
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.50 (+0.71%) Today
$0.00 (0.00%) As of 4:31 AM EDT after-hours

Why Robinhood?

You can buy or sell VRTX and other stocks, options, and ETFs commission-free!

About VRTX

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. Read More The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA. The listed name for VRTX is Vertex Pharmaceuticals Incorporated Common Stock.

Employees
3,000
Headquarters
Boston, Massachusetts
Founded
1989
Market Cap
55.11B
Price-Earnings Ratio
26.74
Dividend Yield
Average Volume
4.14M
High Today
$213.50
Low Today
$209.07
Open Price
$212.50
Volume
1.72M
52 Week High
$306.08
52 Week Low
$189.35

Collections

VRTX Earnings

$0.00
$0.87
$1.74
$2.61
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
$2.32 per share
Actual
Available Oct 29, After Hours

You May Also Like